, induced ovarian Cyp19 gene expression, irrespective of the intrinsic phase of the estrus cycle. In addition to elucidating a physiological function for AhR, our studies also suggest a possible mechanism for the toxic effects of exogenous AhR ligands as endocrine disruptors.
INTRODUCTION
complex with Hsp90, XAP2, and p23 (28, 34, 35) . Upon binding of xenobiotics, such as TCDD and 3-methylcholanthrene (3MC), the receptor complex translocates into the nucleus, where AhR heterodimerizes with the AhR nuclear translocator (Arnt) (61) . Within the nucleus, the AhR/Arnt heterodimer binds to XREs (xenobiotic responsive elements) in the promoters of target genes to activate gene expression. A number of genes encoding drug-metabolizing enzymes, including CYP1A1 and genes encoding UDP-glucuronosyl transferase and glutathione S-transferase, have been identified as targets of AhR (18, 21) . Gene disruption studies have also revealed that AhR functions in the toxicological effects of dioxins, such as teratogenesis, immunosuppression, tumor promotion, and estrogenic action (6, 19, 38, 50, 56) . Despite promoting these multiple adverse effects, AhR is conserved throughout a number of animal species, from invertebrates to vertebrates (20) , suggesting that AhR plays a fundamental role in some physiologic process in addition to mediating the response to xenobiotics.
Ovarian functions are primarily regulated by the hypothalamus-pituitary-gonadal (HPG) axis. Gonadotropin-releasing hormone (GnRH) is discharged from the hypothalamic central nervous system and transported through the portal vascular system to stimulate the gonadotrophs of the anterior pituitary. Subsequently, the anterior pituitary secretes the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) into the venous system. In the ovary, FSH promotes the development of immature follicles, eventually leading to the formation of mature preovulatory follicles. Upon stimulation with LH, the mature follicles rupture, leading to ovulation (52) . Through the period of follicular maturation to ovulation, gonadotropins stimulate ovarian steroid synthesis. FSH upregulates expression of the P450 aromatase (Cyp19) gene (51) , which catalyzes the final step of estrogenesis. Although the genes regulated by estradiol are largely unknown, the involvement of estradiol in folliculogenesis was revealed by the phenotype of Cyp19 knockout (ArKO) mice (17) . Due to impaired synthesis of estradiol, Cyp19 knockout females displayed severely impaired follicular development, resulting in defective ovulation. Interestingly, ovarian defects similar to those seen with ArKO mice were observed upon simultaneous disruption of the estrogen receptor genes, ER and ERß (14) .
Our analysis of AhR-deficient mice revealed a phenotype defective in reproduction that was similar, albeit milder, to that seen with ArKO and ER and ERß double knockout (ER ßKO) mice. AhR-deficient female mice were subfertile, resulting from impaired folliculogenesis and ovulation. These ovarian defects were likely due to insufficient synthesis of estradiol, consistent with the observation that the Cyp19 gene is a novel target gene of AhR within the ovary. While the mechanisms by which AhR induces drug-metabolizing enzyme genes in response to exogenous ligands have been extensively studied, the intrinsic function of AhR has remained unknown. In this report, we have identified an intrinsic function for AhR, in which this receptor adjusts ovarian estradiol concentrations by regulating Cyp19 gene transcription. Based on this novel function for AhR, we propose a molecular mechanism by which the AhR ligands, such as DMBA (9,10-dimethyl-1,2-benzanthracene) and TCDD, also function as endocrine disruptors.
MATERIALS AND METHODS

Fertility assessment. For 3 months, eight AhR
+/+ and AhR -/-females each were mated with AhR +/+ or AhR +/-males. The litter size of each pregnancy, average litter size, and total number of pups were determined. To exclude any effect caused by individual differences in male fertility, two female mice (one AhR +/+ and one AhR -/-) were housed in the same cage (mating cage) with a single male mouse (AhR +/+ or AhR +/-). Once known to be pregnant, female mice were isolated until they gave birth. The numbers of pups were counted on the day of bearing. Female mice were returned to mating cages the next day. This experiment continued for 3 months.
Determination of estrus cycle. To determine the estrus cycle phase, vaginal smears were collected by rinsing the vagina with phosphate-buffered saline (PBS) at 1700 h. Collected smears were mounted on glass slides and stained with Giemsa solution. When angular cells or nucleated epithelial cells occupied the majority of the smear, we determined that the mice were in proestrus or estrus. When a multitude of leukocytes were observed, animals were in metestrus or diestrus (42) . These observations were performed for 21 consecutive days.
Superovulation. The estrus cycle was induced artificially by intraperitoneal injection of 5 U pregnant-mare serum gonadotropin (PMSG) (Teikoku Zouki, Japan) at 1700 h on day 1 of the experiment and 5 U human chorionic gonadotropin (hCG) (Teikoku Zouki, Japan) at 1700 h on day 3. In this superovulation protocol, follicles developed to the preovulatory stage following PMSG treatment, and ovulation was induced by hCG treatment. Experiments attempting to rescue AhR -/-ovulation required the intraperitoneal injection of ß-estradiol (water soluble; Sigma) dissolved in PBS at 1700 h on day 2. Ovulated oocytes were collected from the oviduct and quantified on day 4.
Determination of serum LH concentrations.
One hundred microliters of a GnRH agonist, buserelin (Sigma), in vehicle (PBS-0.3% bovine serum albumin) or vehicle alone was injected into the skin behind the necks of ovariectomized AhR +/+ and AhR -/-females as described previously (11, 57) . One hour after the injection, mice were anesthetized with diethyl ether. After collection of serum samples, serum LH concentrations were determined by radioimmunoassay (SRL, Inc., Japan).
Determination of hormone concentrations. After subjecting mice to the superovulation protocol, we collected ovaries at three time points during the preovulatory period (48 h after PMSG treatment [PMSG + 48 h], hCG + 5 h, and hCG + 8 h). Each ovary was weighed and then homogenized in diethyl ether to a concentration of 10 mg tissue/100 µl methanol. Aliquots (30 µl) of the redissolved materials were subjected to liquid chromatography-mass spectrometry (Applied Biotechnology, Inc., Japan) to determine the concentrations of estradiol and testosterone by comparing intensity values with standard curves made by standard hormones.
Immunohistochemistry. To detect LH, frozen sections (10 µm) were prepared from paraformaldehyde-fixed pituitaries of AhR +/+ and AhR -/-mice, embedded in the TissueTek compound (Sakura Finetechnical Co., Ltd., Japan). After being washed in Trisbuffered saline (50 mM Tris-HCl [pH 7.6], 150 mM NaCl) containing 1 mM CaCl 2 , slides were boiled in 10 mM sodium citrate (pH 6.0) for antigen unmasking (43) and then treated with methanol at -20°C for 30 min. Sections were then incubated with an antibody against the ß subunit of LH (Biogenesis) overnight at 4°C, washed, and treated with a biotinylated donkey anti-rabbit immunoglobulin G (Jackson ImmunoResearch Laboratories, Inc.) for 3 h at room temperature. After being washed, sections were developed with horseradish peroxidase-conjugated streptavidin (Nichirei, Japan) and visualized with diaminobenzidine (Nichirei, Japan) for 10 min at room temperature.
To detect AhR and Cyp19, we prepared paraffin sections (5 µm) from paraformaldehyde-fixed ovaries isolated from AhR +/+ and AhR -/-females given PMSG and hCG (hCG + 5 h). After deparaffinization, sections were treated with proteinase K (20 µg/ml) (Sigma) to unmask antigen epitopes and then treated with hydrogen peroxide (0.3% H 2 O 2 in methanol). Sections were incubated overnight at 4°C with either antiAhR (generously provided by R. Pollenz) or anti-Cyp19 (22) antibody, washed, and then incubated with biotinylated donkey anti-rabbit immunoglobulin G for 3 h at room temperature. After being washed, sections were incubated with horseradish peroxidaseconjugated streptavidin and visualized with diaminobenzidine for 4 min at room temperature.
ChIP assay. We performed chromatin immunoprecipitation (ChIP) as previously described (46, 48) Using eight randomly selected AhR +/+ and AhR -/-females, the total number of pups delivered by the AhR +/+ females was 213, while those delivered by AhR -/-females was 57 ( Table 1) . The average litter size of AhR -/-females was approximately 40% that of the wild type. None of the AhR -/-females examined bore a third litter, and one of these mutant animals was unable to deliver pups during the mating period. Although levels of reproductive activity varied among individuals, these results clearly indicated a decreased fertility of AhR -/-females.
RESULTS
View this table: TABLE 1. Distribution of pups by female genotype
To explore the causes of AhR -/-subfertility, we histologically examined the reproductive organs. Examination of the organs revealed a reduction of the ratio of ovarian weight to body weight in the AhR -/-females to 56% of that seen in the wild-type animals (0.055 ± 0.010% for AhR +/+ versus 0.031 ± 0.003% for AhR -/-, n = 3, P < 0.05). In contrast, the uterus appeared to be unaffected (0.272 ± 0.030% for AhR +/+ versus 0.294 ± 0.049% for AhR -/-, n = 3) ( Fig. 1A and B). Based on histological analyses, the ovaries of AhR -/-animals developed follicles up to the antral/preovulatory stage in the presence of slightly hypoplastic interstitial cells (Fig. 1C) . The corpus luteum, however, was barely detectable in AhR -/-ovaries. As the corpora lutea develop from postovulatory follicles, this observation implied a failure in a final step of follicular maturation and/or ovulation. As failures of follicular maturation and ovulation are frequently accompanied by a disordered estrus cycle (29, 58), we then examined if the ovarian estrus cycle proceeds normally in AhR -/-mice (Fig. 1D) . In wild-type and AhR +/-mice, the estrus cycle progressed regularly, lasting 4 to 5 days. Although we observed considerable individual variation, AhR -/-females displayed significantly disordered estrus cycles (Fig. 1D ), which we classified into three groups. Mice in group I showed a prolonged cycle. In group II, animals exhibited a cycle that was irregularly shortened or prolonged. Unusually prolonged estrus phases were observed for mice classified as group III. Such irregularities were not observed for AhR +/+ or AhR +/-mice.
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As the HPG axis is crucial for progression of the estrus cycle, we examined the tissues of the HPG axis to determine which region is affected in AhR -/-animals. First, we examined the ability of the ovaries of AhR -/-mice to respond to gonadotropins. AhR -/-females aged 3 and 12 weeks were subjected to a standard superovulation protocol, and the numbers of ovulated oocytes in response to gonadotropin stimulation were counted. In AhR -/-mice, the total number of the ovulated oocytes decreased to approximately one-sixth the level seen for age-matched wild-type females (Table 2) . We then examined the production of gonadotropins in the pituitaries of AhR -/-animals by immunohistochemical analysis using an anti-LH antibody ( Fig. 2A) (54) . We measured the concentrations of estradiol in the ovaries at three time points during the preovulatory stage (Fig. 3A) . As AhR -/-females failed to demonstrate normal estrus cycles, we forced the estrus cycle to proceed by gonadotropin stimulation. In AhR -/-females, the concentrations of intraovary estradiol were decreased to 20 to 30% of the levels seen for wild-type animals at all three time points (Fig. 3B) . Testosterone, the precursor of estradiol, was slightly increased in the ovaries of AhR -/-mice in comparison with the concentrations observed for AhR +/+ females (Fig. 3C ). These observations suggest that the decreases in ovarian estradiol are responsible for the reproductive defects of AhR -/-females. We therefore reasoned that an intraperitoneal injection of estradiol at the appropriate time of the ovulatory cycle would rescue the observed phenotype. AhR -/-mice were treated at day 2 with estradiol in the superovulation protocol (Fig. 3D) , and then released oocytes were quantified. Administration of up to 10 ng estradiol to AhR PMSG at day 1 were divided into two groups. One group was treated with various quantities of estradiol, while the other group was given vehicle alone on day 2. The mice from both groups were treated with hCG on day 3, and ovulation was assessed at day 4. (E) Effects of estradiol administration on ovulation in AhR -/-females.
After the treatment of AhR +/+ and AhR -/-females with PMSG and hCG, the oocytes released by ovulation were counted (open bars). AhR -/-females were also given an intraperitoneal injection of 5 to 20 ng 17ß-estradiol (E2) or vehicle alone (filled bars) as described for panel D prior to counting the ovulated oocytes. *, P < 0.025; **, P < 0.005.
AhR is indispensable for proper expression of the Cyp19 gene in the ovary.
As AhR functions as a transcription factor, the above observations suggested that this receptor is involved in the transcriptional regulation of steroidogenic genes. The expression pattern of AhR during folliculogenesis, however, is largely unknown. We therefore examined AhR expression throughout an artificially produced estrus cycle in wild-type mice (Fig.  4A ). AhR mRNA was expressed throughout the preovulatory period. AhRR, a target of AhR transcriptional regulation, represses AhR function (2, 36). Interestingly, the expression of AhRR was upregulated at 6 and 7 h after hCG injection (Fig. 4B) , suggesting that, while AhR becomes functionally active after treatment with PMSG, its activity thereafter is repressed by the action of AhRR. We therefore examined the expression of the Cyp19 gene, whose product is essential for estradiol production, during folliculogenesis. Cyp19 gene expression was activated 48 h after PMSG treatment and downregulated gradually after hCG treatment. This downregulation appeared to coincide with the induction of AhRR expression. We then compared the expression levels of other steroidogenic enzymes within the ovaries of wild-type and AhR -/-mice at 4 and 7 h after hCG treatment (Fig. 4C) . We did not observe any alteration in expression of mRNAs encoding steroidogenic Cyp11A (P450scc), 3ß HSD, and Cyp17 (P450 17 , 17 -hydroxylase) between wild-type and knockout animals at the two time points examined. While Cyp19 mRNA was potently upregulated in wild-type ovaries during the final maturation stage of folliculogenesis induced by hormone treatment (Fig. 4B) , expression of this gene was markedly reduced in AhR -/-ovaries, even at 4 h after hCG treatment. Quantitative RT-PCR demonstrated that the expression of Cyp19 in AhR -/-females was reduced by greater than 90% from that of wild-type animals 4 h after hCG treatment (Fig. 4D) , indicating that Cyp19 mRNA expression was not upregulated in AhR -/-ovaries during hormone treatment.
View larger version
There were no detectable differences between the wild-type and AhR knockout mice in the expression of either p27 kip1 or C/EBPß, both of which are involved in ovulation (16, 29, 47, 58) . As expected, there was no expression of AhRR mRNA in AhR -/-ovaries at 7
h after hCG treatment. To determine if Cyp19 protein levels were also altered in AhR -/-ovaries, we prepared whole-tissue extracts from hormone-treated ovaries (hCG + 5 h) and subjected these samples to Western blot analysis with an anti-Cyp19 antibody. In agreement with the results of our mRNA expression analysis, we detected decreased levels of Cyp19 protein in the ovaries of AhR -/-mice (Fig. 4E) . Consistent with previous reports (53, 62) , immunohistochemical staining with anti-AhR and anti-Cyp19 antibodies demonstrated coexpression of AhR and Cyp19 in the granulosa cells of antral follicles (Fig. 4F) . We also confirmed by immunohistochemistry that Cyp19 protein levels were diminished in the granulosa cells of AhR -/-ovaries (Fig. 4F) .
AhR directly activates Cyp19 gene transcription in cooperation with an orphan nuclear receptor, Ad4BP/SF-1. As the previously described results strongly suggest the involvement of AhR in Cyp19 expression, we examined the mechanism by which AhR regulated Cyp19 gene transcription. The Cyp19 gene has multiple tissue-specific first exons (23, 33, 55) . In the ovary, this gene is transcribed from exon PII (Ex 1d) in a mechanism involving the orphan nuclear receptor Ad4BP/SF-1 (8, 32, 40, 45) . The binding site for Ad4BP/SF-1 is conserved within the 5' upstream regions of the human and mouse genes. We also determined that the human CYP19 and mouse Cyp19 genes have an AhR/Arnt-binding sequence (XRE) 3,756 and 5,058 bp upstream of the ovaryspecific first exon, respectively ( Fig. 5A and B) . We therefore transiently transfected the expression vectors of AhR, Arnt, and Ad4BP/SF-1 into cultured cells to investigate the promoter function of the CYP19/Cyp19 genes. While Ad4BP/SF-1 clearly activated CYP19/Cyp19 gene transcription, cotransfection of AhR and Arnt resulted in only weak activation. Simultaneous expression of AhR/Arnt with Ad4BP/SF-1, however, synergistically activated the Cyp19 promoter ( Fig. 5C and D) . Subsequent expression of AhRR suppressed the transcription activation induced by AhR (Fig. 5C and D) . The observed synergistic activation of the CYP19/Cyp19 promoter by AhR/Arnt and Ad4BP/SF-1 implied a physical interaction between these proteins. To verify this interaction, we cotransfected expression vectors encoding 3xFLAG-AhR, Arnt, and EGFP-Ad4BP/SF-1 and then attempted to coimmunoprecipitate these components by using an anti-FLAG antibody. EGFP-Ad4BP/SF-1, but not EGFP, was coimmunoprecipitated with FLAG-AhR (Fig. 6A) , indicating a potential physical interaction between AhR/Arnt and Ad4BP/SF-1. To investigate if AhR binds to the XRE within the promoter of Cyp19 in vivo, we performed a ChIP assay using chromatin isolated from the granulosa cells of gonadotropin-treated ovaries (Fig. 6B) . PCR analysis of the immunoprecipitates isolated using an anti-AhR antibody (Fig. 6B) revealed that the XRE of the Cyp19 gene was associated with AhR in samples derived from wild-type mice but not AhR -/-mice (Fig. 6C) . This result clearly indicates that AhR was recruited to the Cyp19 promoter in vivo. As the Cyp19 gene is synergistically activated by AhR/Arnt and Ad4BP/SF-1, we assumed that AhR, Arnt, and Ad4BP/SF-1 physically interact on the Cyp19 promoter. We next examined whether anti-AhR antibodies precipitate the Ad4 site of the Cyp19 promoter and whether the antiAd4BP/SF-1 antibody reciprocally precipitates the XRE sequence. Both the XRE-and Ad4-containing sequences of the Cyp19 promoter were recovered in both antiAd4BP/SF-1 and anti-AhR immunoprecipitates (Fig. 6D) . As a control, the sequence between bp -2740 and -2441 was not recovered in either the anti-AhR or the antiAd4BP/SF-1 immunoprecipitate, excluding the possibility that incomplete fragmentation of DNA during chromatin preparation resulted in artifactual coimmunoprecipitation of the Ad4-and XRE-containing sequences. To confirm the interaction between AhR and Ad4BP/SF-1 on the Cyp19 promoter, we investigated whether the XRE is coimmunoprecipitated with Ad4BP/SF-1 in the AhR -/-chromatin (Fig. 6E ). Anti-Ad4BP antibody failed to precipitate the XRE-containing sequence in the absence of AhR, indicating that Ad4BP/SF-1 does not bind directly to the XRE but binds indirectly through interaction with the XRE-bound AhR. In addition, we investigated whether AhR knockout affects Ad4BP/SF-1 binding to the Ad4 site and found that there is no difference in binding of Ad4BP/SF-1 between AhR +/+ and AhR -/-mice (Fig. 6E) . These results clearly demonstrated that both AhR and Ad4BP/SF-1 bind to their cognate binding sites within the Cyp19 promoter and physically interact, probably leading to cooperative enhancement of Cyp19 expression. AhR ligands exerted an estrogenic effect by aberrantly activating Cyp19 gene expression. While Cyp19 is expressed transiently at a particular time point in the preovulatory period, AhR is constitutively expressed in granulosa cells. Inadvertently introduced AhR ligands may exert an estrogenic effect by aberrantly upregulating Cyp19 expression in the ovary. To examine this possibility, we administered DMBA, an AhR ligand, to randomly selected female mice regardless of estrus cycle phase. After a 5-h treatment, we examined the expression of Cyp19 mRNA in the ovary. In a normal estrus cycle, expression of Cyp19 and the resultant estradiol production are induced transiently at proestrus. We observed that Cyp19 mRNA accumulated at proestrus but not at other phases of the estrus cycle in the ovaries of wild-type female mice ( Fig. 7A  and B) . DMBA effectively induced Cyp19 expression at most of the cycle phases except for metestrus. This reagent, however, failed to induce Cyp19 gene expression in the ovaries of AhR -/-mice. Thus, AhR appears to have the potential to activate Cyp19 gene transcription inappropriately in response to exogenous ligands, even when intrinsic estrogen synthesis should not be stimulated. 
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DISCUSSION
In agreement with a previous report (1) Both implantation and follicular maturation are highly dependent on estrogenic action (12) . The phenotype of AhR -/-mice suggested the hypothesis that the observed reproductive failure might be induced by the disruption of genes involved in estrogen production or action. The ovaries of ArKO mice were reported to contain many large follicles filled with granulosa cells, with an absence of a corpus luteum (17) . ER ßKO female mice (14) , completely lacking a receptor-mediated response to estrogen, failed to induce preovulatory follicle formation after superovulation treatment. The female reproduction defects of ArKO and ER ßKO mice resembled those of AhR KO mice, albeit with a more severe phenotype. The similarities between these phenotypes strongly suggested that AhR KO mice have deficits in estrogen production or action. After hypothesizing that estradiol production in the preovulatory period was affected in AhR KO females, we determined that intraovarian estrogen concentrations during the preovulatory stages were decreased in AhR -/-females. Administration of estradiol increased the number of ovulated oocytes in AhR -/-females, suggesting that the subfertility of AhR -/-mice results primarily from reduced levels of ovarian estrogen.
Cyp19 gene transcription mediated synergistically by AhR and Ad4BP/SF-1.
Ovarian sex steroids, such as estrogen and progesterone, are synthesized from cholesterol through multiple reactions in the ovary. Investigation of steroidogenic gene expression revealed that Cyp19 expression was significantly reduced in AhR -/-females.
Immunohistochemical and immunoblotting analyses confirmed the reduced levels of Cyp19 in granulosa cells. As Cyp19 is the rate-limiting enzyme in estrogen synthesis, it is likely that the reduced estradiol concentrations result primarily from lower levels of Cyp19 synthesis in the ovaries of AhR -/-females.
The Cyp19 gene has multiple tissue-specific first exons (23, 33, 55) . A survey of the 5' sequence upstream of the ovary-specific first exon revealed the presence of a potential XRE sequence in both human and mouse genes. The presence of such an XRE sequence has recently been reported to occur within the promoter of the fish ovarian-type CYP19 genes, although a functional analysis remains to be performed (7, 27, 59, 60) . The conservation of XRE among a variety of animal species, however, suggests functionality of this sequence in the ovary-specific expression of Cyp19. In this study, we substantiated this hypothesis by transient transfection and ChIP assays. In addition, the Cyp19 gene proximal promoter contained a functional Ad4/SF-1 site (32). Our investigation of the functional correlation between Ad4BP/SF-1 and AhR revealed that these factors cooperatively enhanced Cyp19 gene transcription. This synergistic action resulted from a physical interaction, revealed by coimmunoprecipitation and ChIP assays.
Recently, another orphan nuclear receptor, LRH-1 (liver receptor homologue 1), has been reported to be selectively expressed in ovarian granulosa cells (15, 24) and to transactivate the ovary-specific Cyp19 promoter in transient transfection assays. Structurally, LRH-1 exhibits homology with Ad4BP/SF-1, and the recognition sequences of these proteins are quite similar. Using the Ad4/SF-1 site from the Cyp19 promoter as a probe, however, electrophoretic mobility shift assays revealed that Ad4BP/SF-1 is the dominant binding factor (9, 10, 15). These observations suggest that Ad4BP/SF-1 and LRH-1 play distinct roles in the regulation of target gene transcription. Superovulation experiments, however, revealed that the Cyp19 gene displayed an earlier peak of expression (reaching a maximum at 48 to 52 h after gonadotropin [PMSG] treatment) than AhRR, which was upregulated as Cyp19 expression began to decline. Although the mechanisms producing this time lag of AhRR expression are unknown, cyclic expression of Cyp19 in the estrus cycle could be explained by a lag in AhRR synthesis. From these observations, it is possible that AhR and AhRR regulate the ovarian biological clock governing the estrus cycle. In support of this possibility, it is interesting to note that expression of CLOCK and BMAL1 (Arnt3), two members of the bHLH-PAS family (to which AhR and AhRR belong), in the suprachiasmatic nuclei of the hypothalamus regulates the expression of their inhibitors, PERs, to generate the biological clock governing circadian rhythms (31) .
In a normal ovarian cycle, the expression levels of AhR appear to be constant. Thus, to transactivate the expression of Cyp19 and AhRR, AhR may also need to be activated.
Although a number of endogenous ligands have been reported to activate AhR (13), the identity of the endogenous ligand required for the activation of AhR in the ovary and the mechanism by which this activation occurs during the estrus cycle remains unknown. In keratinocyte cell lines cultured at low density or in Ca
2+
-free medium, AhR translocates to the nucleus to activate reporter genes, even in the absence of obvious AhR ligands (25). The activation of AhR by phosphorylation has been suggested for such cases (26).
Estrogenic effect of AhR ligand through two distinct mechanisms. In this study, we characterized the subfertility phenotype of AhR -/-female mice, identifying the key role of AhR in Cyp19 gene transcription controlling the temporal synthesis of ovarian estrogen in the estrus cycle. This intrinsic physiological role of AhR provides an explanation for the high degree of AhR conservation throughout vertebrate species. This finding also provides a molecular basis for the estrogenic actions of AhR ligands. DMBA, an AhR ligand, induced Cyp19 expression, leading to unscheduled increases in estradiol regardless of estrus cycle phase. Recently, functional cross talk was reported between AhR and estrogen receptors (ER) (44), and the ligand-bound AhR exerts estrogenic effects through a direct interaction with nonliganded ER molecules associated with estrogen response elements in target gene promoters. Together with our observations, ligand-bound AhR likely exerts an estrogenic effect via two distinct mechanisms, the stimulation of estradiol production through the activation of Cyp19 gene expression and the activation of empty ER by AhR coactivation.
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